Free lookups: 0/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
0 of 3 free lookups remaining Upgrade
New search Medicine profile Streptomycin

Clinical medicine profile

Streptomycin

Amphenicol-class Antibacterial [EPC], Non-Standardized Bacterial Allergenic Extract [EPC]

POM
Evidence state Source-linked Review date not recorded
Route
See product SmPC
Schedule
POM
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • Hypersensitivity to the active substance or excipients.
  • Additional absolute contraindications are indication- and product-specific — consult SmPC.

Precautions

  • Warnings and Storage: Ask a professional before use if pregnant or breastfeeding or if you have severe symptoms.
  • Keep away from children.
  • If you have a reaction to this product that is not positive, discontinue use.
  • Store in a cool and dry place. *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED.
  • This product is not intended to diagnose, treat, cure, or prevent any disease.
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

How to Use Mix with half a cup of water 3-4 times per day. Ages 12 or older, 10 drops. Ages 12-2, 5 drops. Ages 2 and under, consult your Doctor.

Paediatric

See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.

Renal

Review renal impairment dosing; many agents need CrCl/eGFR adjustment.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic

Review hepatic impairment dosing; monitor LFTs if agent is hepatically cleared or hepatotoxic.

03 Clinical use

Use, effects & interactions

Indications

  • Uses Temporarily relieves discomfort due to kidney issues, including occasional frequent urination, foamy urine, headaches, increased blood pressure levels, increased tiredness, itching, lower back discomfort, nausea, loss of appetite, vomiting, need to urinate at night, muscle twitching, and cramps.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED.
  • This product is not intended to diagnose, treat, cure, or prevent any disease.

Adverse effects

  • Ototoxicity, tinnitus, allergic reactions, anaphylactic reactions, headache, neuromuscular block and respiratory arrest with peritoneal cavity administration, nausea, ataxia.
  • Professional use: confirm indication, dose, duration, monitoring and patient counselling points against current Kenya STG / EML and the product SmPC.
  • Document allergy status and key interactions.
04 Pharmacology

Mechanism & disposition

Mechanism is agent-specific.

Mechanism is agent-specific.At receptor, enzyme, ion channel, transpor…Confirm precise molecular mechanism in cur…
Read complete mechanism

Mechanism is agent-specific. At receptor, enzyme, ion channel, transporter or microbial target level, the drug alters a physiological or pathological pathway to produce its therapeutic effect. Confirm precise molecular mechanism in current SmPC / pharmacology reference for this INN before high-stakes decisions.

Onset

Product-specific

Duration

Product-specific

Route

See product SmPC

Elimination

are product-specific. Consider food effects, protein binding, hepatic CYP/UGT

Half-life

when adjusting for organ impairment, age and drug interactions. Verify parameters in the current SmPC.

05 Special populations

Pregnancy, lactation & diet

Pregnancy

Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist.

Lactation

Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data.

06 Kenya market

Brands & loaded prices

FromKES 300
MedianKES 300
Listings2
BrandManufacturerPackObserved price
Di-Iodohydroxyquinoline/Phthalyl Sul- Afya Index / Retail Reference tabs 100's KES 300.00afya_index_book
STREPTO 1 CROWN HEALTHCARE Powder For Injection Unavailable
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; RxNorm (NLM RxNav); PubChem
Last reviewedNot recorded
EvidenceSource-linked
Open source document ↗

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.